However, slowing the digestive process can disrupt the normal movement of stool through your intestines, leading to either constipation or loose stools depending on your individual gut biology
The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place
WITH ALPHA LIPOIC ACID - Designed to work synergistically with Acetyl-L-Carnitine for an enhanced effect
This circuit is called enterohepatic circulation
The workshop concluded that, although treatment resistance is rare, there is a need for additional therapeutic options to address clinical challenges in treating these patients and a need to facilitate international registries to enable risk stratification and optimization of therapeutic strategies